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Abstract Autoregulation, an important feature of the
cerebral circulation, is aVected in many diseases. Since
genetically modiWed mice are a fundamental tool in bio-
medical research, including neuro(bio)logy also in this spe-
cie measurements of cerebral autoregulation (CA) are
mandatory. However, this requires anesthesia that unfortu-
nately signiWcantly impacts cerebral perfusion and conse-
quently might distort CA measurements directly or by
altering arterial pCO2. The latter can be avoided by artiW-
cial ventilation but requires several control measurements
of blood gases, each consuming at least 100 l of blood or
5% of a mouse’s blood volume. To avoid such diagnostic
hemorrhage, we systematically analyzed the eVect of diVer-
ent common anesthetic protocols used for rodents in spon-
taneously breathing mice on CA measured with Laser
speckle perfusion imaging. Halothane, IsoXurane and Pen-
tobarbital abrogated CA and Ketamin/Xylazine as well as
Chloralose had a moderate reproducibility. In contrast, the
rather rarely used anesthetic Ethomidate applied in low
doses combined with local anesthetics had the best repro-
ducibility. Although with this anesthesia the lower CA limit
was lower than with Ketamin/Xylazine and Chloralose as
reported in the handful of papers so far dealing with CA in
mice, we suggest Ethomidate as the anesthetic of choice for
CA measurements in spontaneously breathing mice.
Keywords Cerebral blood Xow · Laser Doppler 
Xowmetry · Cerebral circulation · Pial arteries · 
Anesthetics · Mice
Introduction
Normally, in the brain, perfusion and local metabolic
demand are closely linked (Kuschinsky 1990, 1991), and as
long as the metabolic demand of the brain remains con-
stant, a homeostatic regulatory mechanism called cerebral
auto-regulation (CA) allows the cerebral blood Xow (CBF)
to remain relatively constant during variations in arterial
blood pressure (Paulson et al. 1990). When CA is abol-
ished, Xuctuations of arterial blood pressure are accompa-
nied by either passive reduction or increase in CBF, leading
to syncope and falls, severe cerebral ischemia and edema
(Faraci and Heistad 1998). Mostly, disturbed CA is due to
chronic hypertension (Immink et al. 2004) resulting in
higher CA limits thereby making chronic hypertensive
patients highly vulnerable to brain ischemia in response to
unforeseen hypotension (Strandgaard 1976). Although the
upward shift of the CA limits in chronic hypertension has
been described many years ago (Vorstrup et al. 1984;
Harper 1987; Werber et al. 1990), its cause(s) are still
poorly understood. However, genetically modiWed mice
raise new options to answer also this question. Thus, there
is a certain need for a reliable technique to measure CA in
mice.
Measurements of the CBF response to blood pressure
changes consider either dynamic or static CA (Panerai
2008). Dynamic CA is a transient response to spontaneous
Xuctuations in systemic arterial blood pressure, changes in
posture or other maneuvers resulting in a sudden blood
pressure change. In man, dynamic CA can be assessed with
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250 Exp Brain Res (2010) 207:249–258transcranial Doppler ultrasound and (noninvasive) blood
pressure recordings together with wavelet analysis (Novak
et al. 2004; Hu et al. 2008; Lo et al. 2008). Unfortunately,
such a technique is not available for mice. In rodents
including mice, dynamic CA can be assessed by carotid
clamping (Rosengarten et al. 2006; Schubert et al. 2008).
Static CA is deWned as the steady-state relationship
between CBF and mean arterial blood pressure character-
ized in humans by a constant CBF between mean arterial
blood pressures of approximately 50 and 150 mmHg. Static
CA is measured in experimental animals using Laser Dopp-
ler Xowmetry after exposure of the skull or brain surface
together with manipulations of the blood pressure by con-
trolled bleeding (until complete exsanguination) sometimes
combined with phenylepinephrine infusion via catheters
inserted to the femoral vessels. It is obvious that such mea-
surements require suYcient anesthesia. However, anesthet-
ics themselves inXuence the reactivity of the brain
arterioles either directly e.g. volatile anesthetics dilate
arteries due to attenuation of Ca2+ entry through voltage-
gated Ca2+ channels on vascular smooth muscle cells
(Bosnjak et al. 1992) or, especially in spontaneously breathing
animals, indirectly by respiratory depression that increases
arterial pCO2. Brain vessels are very sensitive to CO2, and
therefore, increased pCO2 values are accompanied by cere-
bral vasodilatation (Kuschinsky 1997) and failure of CA.
The impact of the arterial pCO2 becomes even more obvi-
ous when considering reports showing that the CA dis-
turbed by IsoXurane anesthesia could be improved by
hypocapnia (McCulloch et al. 2005). Although the CO2
problem can be circumvented by artiWcial ventilation of the
animal, the latter introduces an additional trauma and
lengthens surgery. More importantly, the adjustment of the
respirator requires several blood gas analyses, each of it
consuming at least 100 l blood. In larger animals, such as
rats, this is no problem, but in mice 100 l equals about 5%
of the total blood volume. In mice blood loss, prolonged
operations and increased operative trauma per se easily dis-
tort the blood acid base status, most evident from a drop in
base excess (own unpublished observations). The reduced
base excess is either accompanied by a drop in arterial pH
and/or compensatory decrease of the arterial pCO2.
Since pial arteries are also sensitive to hydrogen ions
(Kuschinsky 1982), both changes again inXuence either way
the constriction state of brain arterioles.
The present study aimed to systematically evaluate
diVerent commonly used anesthetic protocols on static CA
in spontaneously breathing mice. SpeciWcally, for measure-
ment of CA in rats Barbiturates (Merzeau et al. 2000;
Paterno et al. 2000), volatile anesthetics such as Halothane
(Verhaegen et al. 1993; Pedersen et al. 2003) or IsoXurane
(Ayata et al. 2004; Tonnesen et al. 2005), Ketamine/Xyla-
zine, Chloralose urethane (Niwa et al. 2002) or Chloralose
alone (Ayata et al. 2004; Rosengarten et al. 2006) have
been used. In general, in the mentioned studies, the rats
were artiWcially ventilated. In a previous study with a set-
ting that is very sensitive to impaired cerebral vasoreactiv-
ity on spontaneously breathing rats, we were using
Ethomidate (Vogel and Kuschinsky 1996) that is known to
have relatively little eVect on CBF (Janssen et al. 1975;
Famewo and Odugbesan 1978). The present study shows
that Ethomidate provides the most consistent measure-
ments, appears to preserve the cerebral vasoreactivity best
and is thus recommended as the anesthetic of choice for CA
measurements in spontaneously breathing mice.
Methods
All experiments were performed on C57Bl6 mice and con-
formed to the Guide for the Care and Use of Laboratory
Animals published by the US National Institutes of Health
(NIH Publication No. 85–23, revised 1996) and institu-
tional guidelines and were approved by the Cantonal Veter-
inary Department, Zurich, Switzerland. Since there was no
gender diVerence for any anesthetic protocol, mice of both
genders were used for the study except for telemetric blood
pressure and heart rate measurements where only males
were used.
Generally, the same anesthetic was used for surgery and
the subsequent experiments. Since in case of Ethomidate
this is not possible, surgery was performed during IsoXu-
rane anesthesia (2–2.5%) and the animals were allowed to
adapt for at least 30 min after discontinuing IsoXurane and
commencing the Ethomidate infusion before the CA mea-
surements were started. All anesthetic protocols are sum-
marized in Table 1. During surgery and the subsequent
experiment, the body temperature of the animals was
kept constant at 37°C using a temperature controlled
heating pad.
After induction of anesthesia, the mice were equipped
with catheters in both femoral arteries and veins for the
measurement of blood pressure, heart rate (PlugSys, Hugo
Sachs Electronics, Germany and PowerLab, ADInstru-
ments, Germany), blood gases and acid–base status
(AVL700, Radiometer Medical, Denmark) and hematocrit
and the infusion of anesthetics (cf. Table 1) and phenylepi-
nephrine. Before closing the wounds, a drop of 2% Lidoc-
ain (Streuli, Switzerland) was applied to the wound.
Thereafter the mice were placed in a stereotactic frame, the
scull was exposed and Xushed with 2% Lidocain. Then a
Laser speckle perfusion imager (moorFLPI, Moor Instru-
ments, UK) was adjusted to its maximal magniWcation and
Wve regions of interest (ROI’s, 3 on the left and 2 on the
right hemisphere) were deWned avoiding visible vessels. In
accordance with others (Ayata et al. 2004), preliminary123
Exp Brain Res (2010) 207:249–258 251experiments have shown that the transparency of the scull
of mice is high enough to not reduce signiWcantly the laser
signal as long as it is kept wet with artiWcial cerebrospinal
Xuid or 0.9% saline warmed to 37°C. The images were
acquired at 25 Hz and the traces of the ROI’s were sampled
with a time constant of 0.5 s. During surgery and the subse-
quent measurements of static CA, animals were allowed to
breathe pure oxygen spontaneously.
At the very beginning of the recordings, a screwdriver
handle was dropped onto the arterial line connected to the
blood pressure transducer. This produced an artifact simul-
taneously in both the blood pressure and the laser perfusion
trace that was later used to synchronize both traces for
oZine calculation of the CA limits. Then the mice were
slowly exsanguined via the second arterial line while con-
tinuously recording the laser speckle perfusion and blood
pressure signal. The exsanguination rate was adjusted man-
ually by continuous inspection of the blood pressure trace
to get a linear and constant decrease of the blood pressure
(about 1 mmHg/min, total exsanguination time: 35–40min).
In addition, some animals anesthetized with Ethomidate,
Chloralose or Ketamine/Xylazine received an infusion of
phenylepinephrin (Sintetica, Switzerland, 1 ng/g/min) that
was started 3 min before starting the CA measurement and
lasted until its end.
For determination of the CA limits, all laser speckle per-
fusion and blood pressure values before the marker artifact
were discarded and then the data were averaged in ten-sec-
ond intervals using macros written in Excel (Microsoft).
The laser speckle perfusion values obtained this way were
then plotted as a function of the corresponding blood pres-
sure values. Then the lower CA limit was determined by
linear extrapolation by starting with the lowest blood pres-
sure values and the upper limit in a similar way by starting
with the highest blood pressure values as described elsewhere
for the “plateau constraint” (Pedersen et al. 2003). This was
done separately for each of the Wve ROI’s. The Wnal CA
limits for each animal were deWned as the mean of those
determined for each ROI, and these mean values were used
for statistical analysis. The intra-individual variation of the
ROI’s was very low (coeYcient of variation: 1.3–2.8%).
Another experimental group was equipped with telemet-
ric blood pressure sensors (TA11PA-C10 transmitter, Data-
Sciences International, USA) as described recently (Schuler
et al. 2009, 2010) to assess the eVect of anesthesia on arte-
rial blood pressure and heart rate in comparison with con-
scious animals. In an additional control experiment, the
eVect of switching from normal air to pure oxygen on Laser
speckle imaging during IsoXurane and Ethomidate anesthe-
sia has been assessed.
Data are presented as means § standard deviation and
were analyzed with the GraphPad PRISM 4 Software
(version 4.01) using ANOVA and Students t test or
Kruskal–Wallis test (in case the number of values were not
equal for all groups) for unpaired samples with Bonferroni’s or
Dunn’s post hoc test, respectively. P values of <0.05 were
considered signiWcant.
Results
Table 2 shows the physiologic variables of all naïve ani-
mals used for the study. The blood gas values of mice
treated with phenylepinephrine were similar, but mean arte-
rial blood pressure as well as heart rate were considerably
higher by 53 and 61%, respectively (not shown). The most
striking diVerence between the groups of naïve mice was
found concerning the arterial pCO2 with highest values in
Pentobarbital and Ketamine/Xylazine anesthetized mice
and lowest during IsoXurane anesthesia. In addition, heart rate
Table 1 Anesthetic protocols
a After Wnishing the preparation during IsoXurane anesthesia
b 16.6 mg Chloralose dissolved together with 25 mg sodiumtetraborate * 10H2O/ml H20
c After Wnishing the preparation changed to i.v. application
Active component Trade name Provider Route Initial dosage Maintenance dosage
Ethomidate Ethomidate 
Lipuro
B. Braun Medical AG, Sempach, 
Germanya
i.v. 80 g/min 
for 3 min
14–26 g/min
Ketamine/Xylazine Rompun/
Narketan
Ratiopharm, Ulm, Germany/Bayer, 
Leverkusen, Germany
i.p. 90 mg kg¡1/
9 mg kg¡1
40 mg kg¡1 every 
30 min/4 mg kg¡1 
every 30 min
Alpha-chloralose Siqma-Aldrich GmbH, Buchs, 
Switzerlandb, c
i.p./i.v. 25 mg kg¡1 75 mg kg¡1 h¡1
IsoXurane IsoFlo Abbott AG, Baar, Switzerland Inhalation 5% 1.50%
Haiotnane Halothane Arovet AG, Zollikon-Station, Switzerland Inhalation 4% 0.90%
Pentobarbital Vetanarcol Veterinaria AG, Zurich, Switzerlandc i.p./i.v 100 mg kg¡1 1 mg kg¡1 h¡1123
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Exp Brain Res (2010) 207:249–258 253is lower in those anesthetic regimes that result in respira-
tory depression such as Ketamine/Xylazine and Pentobar-
bital. Most likely this is an eVect of hypercapnia that has
been shown to induce bradycardia in mice (Campen et al.
2004). The high pO2 values in all experimental groups are
due to pure oxygen breathing. The telemetric blood pres-
sure and heart rate data had been obtained in the context
of a recent study (Schuler et al. 2010). In comparison with
these data, all anesthetics reduced blood pressure and
heart rate. Switching from air to pure oxygen did not
aVect the blood pressure or the Laser speckle signal (data
not shown).
Figure 1 shows example autoregulation curves (mean of
all ROIs of a single animal) of all anesthetics tested without
parallel phenylepinephrine infusion. Halothane as well as
IsoXurane resulted in complete abrogation of CA that is for
IsoXurane in agreement with previous reports (Ayata et al.
2004). A bit surprisingly, since also used in several studies
dealing with CA, Pentobarbital anesthesia also was associated
with a complete loss of CA. This is most probably due to
the anesthesia-induced hypercapnia of the spontaneously
breathing mice (cf. Table 2).
In Ketamine-/Xylazine- and Chloralose-anesthetized mice,
the lower CA limit was around 44 and 53 mmHg, respec-
tively, which is in agreement with previous reports on mice
investigated using Chloralose (Ayata et al. 2004). In con-
trast, the lower CA limit in Ethomidate-anesthetized mice
was considerably lower at around 25 mmHg and the drop
was more abrupt than in Ketamine-/Xylazine- or Chloralose-
anesthetized mice (cf. Fig. 1). However, in naïve ani-
mals, the diVerences in lower limit of CA reached statistical
signiWcance only for the comparison between Ethomi-
date and Chloralose. For Ethomidate, Ketamine/Xylazine
and Chloralose, the lower limit was also determined during
phenylepinephrine infusion resulting in the same limits
(Fig. 2); however, between these groups, none of the diVer-
ences were statistically signiWcant. This is most likely
due to much larger data scatter in Ketamine/Xylazine and
Fig. 1 Representative examples of autoregulation curves (mean of all
Wve ROI’s of a single animal) obtained with the diVerent anesthetics
as indicated. The anesthetics shown on the right completely abrogated
cerebral autoregulation (CA). For Ethomidate, the range of CA is larg-
est. Also in Ketamine-/Xylazine-anesthetized mice, the lower as well
the upper CA limit can be seen, whereas in Chloralose-anesthetized
mice, the upper limit is not visible since with falling blood pressure
cerebral perfusion is reduced rather in an exponential fashion until the
lower CA limit is reached123
254 Exp Brain Res (2010) 207:249–258Chloralose anesthetized mice compared to those anesthetized
with Ethomidate. Accordingly the coeYcient of variation
was between 3- and 3.9-times lower during Ethomidate
anesthesia than during Ketamine/Xylazine and Chloralose
anesthesia. These latter data indicate that Etomidate has
the best reproducibility concerning the measurement of the
lower CA limit.
Regarding the upper limit in some animals of all anesthetic
protocols, the determination was not possible since above
the lower limit the CA curves showed an exponential shape.
This was even more the case in phenylepinephrine-treated
mice. However, the best detection rate of an upper limit
was found in Ethomidate-anesthetized mice. In contrast
to the lower limit, there were no major diVerences in the
upper limit between naïve mice anesthetized with Ethomi-
date, Ketamine/Xylazine or Chloralose. In phenylepineph-
rine-treated mice, the upper limit tended to be higher during
Ketamine/Xylazine and Chloralose anesthesia. In contrast to
the lower limit, the measurements of the upper limit
appeared to be more stable (maximum coeYcient of variation
of about 22%) irrespective of the fact that sometimes the
upper limit could not be determined at all.
By taking the measurements of the lower and upper
limits together in naïve Ethomidate anesthetized mice, the
CA range was considerably larger (42 mmHg vs. 9.9 and
19.2 mmHg during Ketamine/Xylazine and Chloralose
anesthesia). During phenylepinephrine treatment, the
diVerences between lower and upper limit were quite sim-
ilar (34.6, 35.6 and 36.8 mmHg). The latter data however
are based only on a few mice and thus should be taken
with caution.
In addition, we aimed to assess the vasodilatation
induced by the anesthetics themselves as well as the vasodi-
lator capacity (deWned as the diVerence between the initial
and maximum perfusion per mmHg) in response to the fall-
ing blood pressure during the diVerent anesthetic protocols.
Although Laser speckle perfusion imaging does provide
only semi-quantitative data, the measurements are quite sta-
ble as determined with a motility standard provided by the
manufacturer of the imager along with the device. Thus, we
calculated the initial Laser speckle perfusion/mmHg before
exsanguination was started. In addition, we calculated the
diVerence between the initial perfusion/mmHg and the
maximal perfusion/mmHg before the Wnal drop of the cere-
bral perfusion. In case there was no increase observed from
the initial value, the perfusion/mmHg value at a blood pres-
sure of 50 mmHg was taken. Figure 3 shows that there were
large diVerences in the initial perfusion between the diVer-
ent anesthetics with a maximum factor of nearly 3 between
Ethomidate and Halothane. Note that Halothane, IsoXurane,
and Pentobarbital, which abrogated CA, exhibit the highest
initial laser speckle perfusion as well as perfusion/mmHg
values. This indicates anesthesia-induced vasodilatation. In
line with this, the maximal increase in perfusion/mmHg as
a result of the falling blood pressure was found also in
Ethomidate-anesthetized mice (Fig. 4). In contrast, in Halo-
thane-, IsoXurane-, and Pentobarbital-anesthetized mice,
sometimes no increase at all could be observed but rather a
continuous decrease of perfusion/mmHg from the very
beginning until the end of the experiments. These Wndings
indicate that Halothane, IsoXurane as well as Pentobarbital
abrogate the vasoreactivity of brain vessels in spontane-
ously breathing mice and are therefore unsuited for CA
measurements in this specie.
Fig. 2 Mean lower (a) and upper (b) CA limits determined mice with
and without phenylepinephrine treatment. a The lower CA limit was
the same with or without phenylepinephrine treatment but lowest dur-
ing Ethomidate anesthesia. However, this was statistically signiWcant
only compared to Chloralose (both untreated, *P < 0.05), most likely
due to the high data scatter in the Ketamine/Xylazine and Chloralose
groups as indicated by the coeYcient of variation (numbers in the Wrst
row). The more than 3-times smaller coeYcient of variation indicates
a better reproducibility during Ethomidate anesthesia compared to
both, Ketamine/Xylazine and Chloralose. b Determination of the up-
per limit was hampered by the fact that some traces showed an expo-
nential shape above the lower CA limit (cf. Fig. 1, Chloralose). In
keeping with this limitation, the upper CA limits in Ketamine-/Xyla-
zine- and Chloralose-anesthetized animals tended to be higher in case
of phenylepinephrine treatment in contrast to Ethomidate-anesthetized
mice. In Ketamine-/Xylazine- and Chloralose-anesthetized mice, the
coeYcient of variation was lower than that for the lower CA limit and
in Ethomidate-anesthetized mice similar to that of the lower limit.
*P < 0.05 vs. Chloralose + phenylepinephrine, means § SD, N = number
of animals per group123
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The present study clearly indicates that in spontaneously
breathing mice, the anesthetic protocol for measurement of
CA aVects both the absolute values as well as the reproduc-
ibility of the measurements. In view of the high value of
transgenic mice which are often also costly pre-treated
before CA is Wnally measured, good reproducibility is an
important point in choosing the anesthetic protocol to
detect small but nevertheless biologic relevant diVerences
between experimental groups. Here, we show that Ethomi-
date has an excellent reproducibility and retains reactivity
of the cerebral vasculature best. Therefore, from all anes-
thetics tested in the present study, Ethomidate appears to be
the anesthetic of choice for the measurement of CA in
spontaneously breathing mice.
The best way to exclude any inXuence of anesthetics on
mice appears to measure CA in the conscious state
(Lacombe et al. 2005; Joutel et al. 2010). In these papers,
the perfusion was quantiWed with Laser Doppler Xowmetry
via optical Wbers glued to the scull of mice also equipped
with catheters inside the femoral vessels. The animals had
been placed in restrainers for 2 h before starting the Wnal
measurements. Laser speckle perfusion imaging that has
been used in the present study, however, requires the scull
to be Wxed since it cannot distinguish tissue from red cell
movements. In addition, restraining animals equipped with
optical probes at the scull and catheters inside the femoral
Fig. 3 Initial laser speckle per-
fusion (white bars) and initial 
perfusion normalized to the 
mean arterial blood pressure 
(gray bars). These data should 
be indicative for the vasodilata-
tion state induced by the diVer-
ent anesthetics. Halothane, 
IsoXurane, and Pentobarbital 
that abrogated CA have the high-
est initial laser speckle perfusion 
as well as perfusion/mmHg val-
ues. I IsoXurane, 
P Pentobarbital, H Halothane
Fig. 4 DiVerence between the 
initial perfusion/mmHg and the 
maximal perfusion/mmHg. In 
contrast to Ethomidate, Keta-
mine/Xylazine and Chloralose 
anesthetized mice in Halothane, 
Pentobarbital and IsoXurane 
anesthetized mice more (Halo-
thane) or less often (IsoXurane) 
no increase at all from the initial 
perfusion/mmHg value could be 
observed. In such a case, the per-
fusion/mmHg value at a blood 
pressure of 50 mmHg was taken. 
These data indicate that the high-
est vasodilatation reserve is 
present during Ethomidate anes-
thesia. E Ethomidate, 
K Ketamine/Xylazine, 
C Chloralose123
256 Exp Brain Res (2010) 207:249–258vessels, even when treated with local anesthetics, for such a
long period with Wnal exsanguinations in the conscious
state is diYcult to get permitted in countries with strong
animal protection laws such as Switzerland. Nevertheless
CA measurements in conscious mice might allow assessing
where the real limits are lying in this specie. In the afore-
mentioned papers, the CA limits were determined in a
diVerent way when compared to the present study. These
authors deWned the lower limit as 90% and the upper limit
as 110% of the initial blood Xow. This way they obtained in
wt mice a lower limit of about 60 mmHg, a value that is
15–20 mmHg above those reported by others for Ketamine/
Xylazine and Chloralose (Niwa et al. 2002; Ayata et al.
2004; Tonnesen et al. 2005; Rosengarten et al. 2006) and
that of the present study using the same anesthetics. How-
ever, when trying to apply the method for calculating the
lower limit used in the present study (Pedersen et al. 2003)
to the data of Lacombe et al. (2005) and Joutel et al. (2010)
a lower limit of about 40–45 mmHg appears to be present
also in their data. Thus, the lower CA limit in conscious
mice is most close to our values and those of others
obtained during Ketamine/Xylazine and Chloralose anes-
thesia. In Ethomidate-anesthetized mice, however, the
lower limit is clearly lower, although there was only minor
signiWcance to the other anesthetics most likely due to
much high data scatter in the Ketamine-/Xylazine- and
Chloralose-anesthetized groups (cf. coeYcients of varia-
tion, Fig. 2a). Concerning the upper limit, Lacombe et al.
(2005) found during phenylepinephrine infusion and using
their 110% method a value of 120 mmHg. Again when
applying the method of the present study for determining
the upper limit to their data the upper limit appears to be
diVerent, namely about 90 mmHg. Thus, the range of CA in
mice appears to be about 40 mmHg. In naïve mice, a simi-
lar CA range was found only for Ethomidate-anesthetized
mice, whereas in Ketamine-/Xylazine- and Chloralose-
anesthetized mice, the range was 4- and 2-times smaller,
respectively. In contrast, in phenylepinephrine treated mice,
the CA range was not diVerent between the diVerent anes-
thetic protocols and with 35 mmHg also comparable to that
found in naïve Ethomidate-anesthetized mice and that esti-
mated from the data of conscious mice (Lacombe et al.
2005). Thus, Ethomidate appears to preserve the CA range
best but to shift the autoregulation curve slightly leftward.
In contrast, in naïve Ketamine-/Xylazine-and Chloralose-
anesthetized mice, the CA range was clearly reduced sug-
gesting an impaired vaso-reactivity that is also evident from
the reduced maximal perfusion change per mmHg in
response to the blood pressure drop (cf. Fig. 4). This is also
in line with the lowest initial perfusion per mmHg in
Ethomidate anesthesia (cf. Fig. 3), indicating a higher ini-
tial cerebrovascular constriction state and thus a higher
vasodilatatory reserve.
Concerning Halothane only studies in rats could be
found (Verhaegen et al. 1993; Pedersen et al. 2003), but
Halothane slowly disappears from the market. In principle,
the pharmacological action of Halothane is similar to that
of IsoXurane but the wash-in and -out of IsoXurane is faster
(Yasuda et al. 1989) enabling better control of the anesthe-
sia. Thus, in recent years, IsoXurane became the standard
volatile anesthetic also in animal research and was used in
rats and mice for the measurement of cerebral blood Xow
under diVerent conditions including functional stimulation
(Ayata et al. 2004; Joutel et al. 2010) and cerebral autoreg-
ulation (Ayata et al. 2004; Tonnesen et al. 2005). One paper
directly compared in mice IsoXurane with Choralose con-
cerning CA as well as functional stimulation (Ayata et al.
2004) and found according to our results an abrogation of
CA during IsoXurane anesthesia. In contrast, functional
stimulation was not diVerent between IsoXurane and Chlo-
ralose that is in line with the data of others also reporting in
mice a preserved functional stimulation during IsoXurane
anesthesia (Lacombe et al. 2005; Joutel et al. 2010) at an
inspired concentration of 1.2–1.5%. We did not yet test Iso-
Xurane and functional stimulation in mice, but previously in
a study on rats, we used Ethomidate (Vogel and Kuschin-
sky 1996) because any functional stimulation-related CBF
eVect was abolished during Halothane anesthesia. This is in
line with studies showing that the reactivity of the smooth
muscle is impaired by volatile anesthetics (Bosnjak et al.
1992) as well with the data of the present study showing
that IsoXurane like Halothane results in a complete loss of
CA (cf. Fig. 1). However, a study dealing with the ortho-
static regulation of mice claimed that CA was preserved
during 1% IsoXurane anesthesia (Foley et al. 2005). With-
out measuring CA directly, this was concluded from the
fact that phenylepinephrine increased mean arterial blood
pressure but not CBF. However, phenylepinephrine results
in a considerable tachycardia (in the present study by 61%)
that in turn impairs cardiac output. Thus, an increased mean
arterial blood pressure during phenylepinephrine treatment
paralleled by a reduced cardiac output might leave CBF
unchanged independent of an autoregulatory action of the
cerebral vasculature.
The most signiWcant problem when using Pentobarbital
in spontaneously breathing animals is ventilatory depres-
sion that results in hypercapnia induced cerebral vasodilata-
tion and subsequent loss of CA (cf. Table 2 and Fig. 1). To
our knowledge, it has not yet been shown whether Barbitu-
rates have also direct (pCO2-independent) eVects on CA,
but dosages of pentobarbital previously published for para-
lyzed and artiWcially ventilated rats (Paterno et al. 2000)
were not suYcient to keep our mice in the tolerance state.
Consequently, we had to increase the dosage resulting in
the highest arterial pCO2 values of all groups. The present
study was designed to test the eVects of the diVerent anesthetic123
Exp Brain Res (2010) 207:249–258 257protocols in spontaneously breathing mice, because the
great disadvantage of artiWcial ventilation is additional
trauma and the necessity of several determinations of the
arterial blood gases to adjust the respirator. Each blood
gas determination requires at least about 100 l of arte-
rial blood. Thus, 2–3 determinations of blood gases can
bring the animals close to a hemorrhagic shock. Although
the lost blood can be replaced, e.g., by saline, this
reduces the hematocrit and consequently the oxygen
transport capacity of the blood that in turn increases CBF
(Waschke et al. 1994). Of note, we supplemented the
mice during the experiments with pure oxygen. In con-
trast to the vasodilating eVect of hypoxia, CA is not
diVerent in man breathing either normal air or pure oxygen
(Ogoh et al. 2010). In line with this study, we found no
diVerence in the Laser speckle signal when switching from
air to pure oxygen.
Using anesthetics for CA measurements has the princi-
ple and unavoidable disadvantage of inXuencing CBF and
thus the CA measurement itself. In addition, anesthesia-
induced hypercapnia might disturb CA. The same hold for
intermittent sometimes un-recognized hypoxia that can
occur during anesthesia especially when induced by injec-
tions. Since the brain is very sensitive to shortage of oxy-
gen hyperoxia has been found to be very eVective as
emergency treatment in traumatic brain injury or stroke
(Kumaria and Tolias 2009). Because it drastically reduces
the risk of hypoxia during anesthesia but does not alter
brain perfusion (cf. previous paragraph), we recommend
supplying the mice with pure oxygen during surgery and
subsequent CA measurements. Although hypercapnia and
hypoxia can be avoided by artiWcial ventilation, this
requires several determinations of the arterial blood gases,
in mice easily resulting in a “diagnostic hemorrhage”. In
addition, one should be aware that transferability of data
from animal experiments to the clinics could be hampered
by the fact that diVerent researchers perform CA measure-
ments in a diVerent way. One underestimated diVerence
between protocols is anesthesia. Here, we aimed to Wnd an
anesthetic protocol that requires as little surgery as possi-
ble, to allow measurements in spontaneously breathing ani-
mals and has a high reproducibility. Such an anesthetic
protocol reduces uncontrolled inXuences of side parameters
on the data and thus increased the transferability of the data
into clinics. Reproducibility is also a very important point
in light of using valuable genetically modiWed mice that
might be available only in limited numbers e.g. due to
reduced breeding success. In this context also small system-
atic errors can be tolerated as long as the good reproducibil-
ity exceeds this disadvantage. Taken together, we feel that
Ethomidate is—of the anesthetics tested here—the best due to
its ability to keep the arterial pCO2 in the normal range without
the need of artiWcial ventilation, its excellent reproducibility,
and a CA range closest to that of conscious animals
(Lacombe et al. 2005; Joutel et al. 2010). The fact that
Ethomidate shifts the CA curve slightly leftward could
even be interpreted as an advantage, since this allows
catching also the upper CA limit without phenylepinephrine
treatment.
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